Monday, October 23, 2017

US FDA News: Octagam [Immune Globulin Intravenous (human)] 10 Percent Liquid Preparation]: Voluntary Market Withdrawal

Suspend further administration of octagam 10% from production lots K724B8541 and K725A8541.
Read more: Octagam [Immune Globulin Intravenous (human)] 10 Percent Liquid Preparation]: Voluntary Market Withdrawal